Sheehan syndrome, a rare but serious postpartum condition, results from ischemic damage to the anterior pituitary gland caused by significant bleeding during or after childbirth. This damage leads to varying levels of pituitary hormone deficiencies, with symptoms ranging from lactation failure and amenorrhea to hypothyroidism and adrenal insufficiency, which can appear immediately after delivery or much later. Anxiety is increasingly noted as a significant comorbidity in Sheehan syndrome. The chronic hormonal deficits, especially of cortisol and thyroid hormones, are linked to neuropsychiatric symptoms, including anxiety. Secondary adrenal insufficiency leads to reduced cortisol levels, impairing the stress response and potentially heightening anxiety. Similarly, hypothyroidism affects mood and cognitive functions, further complicating mental health. Diagnosing Sheehan syndrome relies on clinical history, particularly obstetric hemorrhage, and pituitary hormone tests, with MRI scans often showing an empty sella or other pituitary abnormalities. Treatment involves lifelong hormone replacement tailored to specific deficiencies, including glucocorticoids, thyroid hormones, sex steroids, and sometimes growth hormone. Managing anxiety in these patients necessitates a multidisciplinary approach, incorporating psychological support, counseling, and potentially medications such as anxiolytics or antidepressants. Ensuring optimal hormone replacement is crucial, as it can help alleviate neuropsychiatric symptoms. In summary, Sheehan syndrome presents complex endocrine and psychiatric challenges. Early diagnosis and a comprehensive treatment plan addressing both hormonal and mental health aspects are essential for improving the quality of life for affected women.